TB-500 (Thymosin Beta-4): What the Research Says About the Repair Peptide
TB-500 is one of the most-referenced recovery peptides in the research literature, and it is studied as a synthetic version of a naturally occurring repair signal. TB-500 is a fragment associated with Thymosin Beta-4, a protein found in nearly every cell type and present at especially high levels at sites of tissue injury. This overview summarizes what the literature describes about its mechanism, how it compares to the recovery peptides we carry, and how researchers handle it in the lab.
What TB-500 Is
Thymosin Beta-4 is a 43-amino-acid protein involved in cell migration, tissue organization, and wound response. TB-500 refers to a synthetic peptide based on the biologically active region of this molecule, which makes it easier to produce and study than the full-length protein.
Because it concentrates the active sequence into a smaller, more stable molecule, TB-500 is frequently grouped with other "repair-signal" research peptides that isolate a single biological pathway.
What the Research Describes
The most studied mechanism of Thymosin Beta-4 is its high-affinity binding to G-actin, the monomeric form of the cytoskeletal protein actin. By sequestering actin monomers, it influences the assembly and disassembly of the cytoskeleton — a process central to how cells migrate and reorganize during tissue repair.
The literature also describes effects beyond actin binding, including the upregulation of vascular endothelial growth factor (VEGF) and support for endothelial cell migration and new blood-vessel formation (angiogenesis). Thymosin Beta-4 expression has been reported to rise several-fold during early angiogenesis in experimental models, consistent with a role in vascular repair.
These findings come from preclinical and laboratory research. No regulatory authority recognizes TB-500 as an approved treatment, and reported figures should be read as exploratory rather than clinical guidance.
How It Compares to Carried Recovery Peptides
TB-500 is most often discussed alongside BPC-157, a different repair-oriented peptide with a distinct mechanism. The two are so frequently compared that we wrote a dedicated piece on it — see BPC-157 vs TB-500. You can also find TB-500 alongside related compounds in our roundup of recovery and tissue-repair research peptides.
For researchers interested in combination study designs, TB-500 also appears in the Wolverine research blend, discussed in our Wolverine blend overview.
Why TB-500 Stays Relevant
Interest in TB-500 has stayed steady because its actin-regulating mechanism touches a process common to many tissue types rather than a single organ. This generality is exactly why it remains a useful reference compound in cytoskeletal and wound-healing research.
Handling and Storage
Like most research peptides, TB-500 is supplied as a lyophilized (freeze-dried) powder. It is reconstituted with bacteriostatic water before use in the lab.
Lyophilized powder is generally stored cold and protected from light; reconstituted material is kept refrigerated and used within a limited window. For step-by-step mixing and volume math, see our guide to reconstituting peptides.
The Bottom Line
TB-500 is a synthetic peptide based on the active region of Thymosin Beta-4, studied for its role in actin regulation, cell migration, and angiogenesis. It is not approved for human use, but researchers comparing tissue-repair pathways can explore it alongside the other recovery compounds in our catalog.
Research use only. This article is educational and is not medical, legal, or financial advice. The compounds discussed are not approved for human or veterinary use, consumption, or therapeutic application.